Oncology & hematology review
Oncol Hematol Rev
· ISSN (print) 2052-3815
· 1 paper in corpus
review
2013
Hormonal therapies such as progestins have only modest activity in the treatment of advanced endometrial cancer. Mechanisms of resistance to progestin therapy are not well understood. However, activation of the PI3K/AKT/mTOR pathway has bee…